Resource bibliography (2005)

CO-OCCURRING DISORDER RESOURCE BIBLIOGRAPHY (2007)
Compiled by Kenneth Minkoff, M.D. and Christie A. Cline, M.D., M.B.A. American Association of Community Psychiatrists, Level of Care Utilization System (LOCUS 2001), American Association of Community Psychiatrists, Principles for the care and treatment of individuals with co-occurring psychiatric and substance disorders. Dallas, AACP 2000. (AACP Web site: www.commpsych.org ) Addiction Technology Transfer Center Network. The Change Book: a blueprint for technology transfer. 2004. www.nattc.org/changebook American College of Emergency Physicians. Clinical Policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. April, 2005 American Society of Addiction Medicine. Patient Placement Criteria 2ND Edtion Revised. Alexander MJ. Women with co-occurring disorders: an emerging profile of vulnerability. Am. J. Barreira, P, Espey, E, et. al. Linking substance abuse and serious mental illness service delivery systems: initiating a statewide collaborative. Journal of Beh Health Serv Res, 2000. 27: 107-13. Bastiaens, L, Francis G, & Lewis, K. The RAFFT as a screening tool for adolescent substance use disorders. Am. J. Addictions. (2000) 9:10-16. Bellack AS, Bennett ME, & Gearon JS. Behavioral treatment for substance abuse in people with Bellack AS & DiClemente CC. Treating substance abuse among patients with schizophrenia. Psych Bogenschutz MP. Specialized 12-step programs and 12-step facilitation for the dually diagnosed. Boyle P & Weider B. Creating and sustaining IDDT programs: lessons learned in Ohio. J. Dual Dx. Broner N, et al. Effects of diversion on adults with co-occurring mental illness and substance abuse: outcomes from a national multi-site study. Behav Sci & the Law (2004) 22:519-41 Brunette, M, & Drake, RE. Gender differences in homeless persons with schizophrenia and substance Bucciarelli C. Addicted and Mentally Ill. Stories of courage, hope, and empowerment. Binghamton, Burton Donna, Cox Arthur, Fleisher-Bond Margo, Cross Training for Dual Disorders; A Comprehensive Guide to Co-occurring Substance Use and Psychiatric Disorders. New York, NY. Vantage Press. 2001. Canadian Centre on Substance Abuse. Core competencies for Canada’s Substance Abuse Field, version 1.0. CCSA. Ottawa 2007. www.ccsa.ca Carey KB, Leontieva, L, et al. Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders. Clin Psychol. Sci. Prac. (2007) 14:39-57. Carroll KM & Onken LS. Behavioral therapies for drug abuse. Am. J. Psychiat. (2005). 162 (8): 1452- Center For Substance Abuse Treatment. A guide to substance abuse services for primary care clinicians. Treatment Improvement Protocol #24. CSAT, Washington, 1997 Center For Substance Abuse Treatment. Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol #35. CSAT, Washington, 1999. Center For Substance Abuse Treatment. Substance Abuse Treatment for persons with HIV/AIDS. Treatment Improvement Protocol #37. CSAT, Washington, 2000. Center for Substance Abuse Treatment. Substance Abuse Treatment for Individuals with Co-occurring Disorders. Treatment Improvement Protocol #42, CSAT, Washington, 2005 Center For Substance Abuse Treatment. Detoxification and SA Treatment. Treatment Improvement Protocol #45. CSAT, Washington, 2006 www.ncadi.samhsa.gov . Center For Substance Abuse Treatment. Substance Abuse Treatment for persons with co-occurring disorders (TIP 42) inservice training. CSAT, 2007 www.kap.samhsa.gov Centre for Addiction and Mental Health (CAMH). Best Practices: concurrent mental health and substance use disorders. Ottawa: Health Canada. 2001 Centre for Addiction and Mental Health (CAMH) Beyond the label: an educational kit for addressing stigma for people with concurrent disorders. www.camh.net. (2005) . Centre for Addiction and Mental Health (CAMH). Navigating screening options for concurrent disorders. (cd-rom). www.camh.net. (2006) Chichester C, Hornsby H, et al. Final report and evaluation: a project to establish a more welcoming system for people with co-occurring disorders in Maine. Hornsby-Zeller: Portland, ME (2006). Cline, C and Minkoff K, Substance Abuse and Mental Health Services Administration. A Strength Based Systems Approach to Creating Integrated Services for Individuals with Co-occurring Psychiatric and Substance Abuse Disorders-A Technical Assistance Document. NMDOH/BHSD Dec. 2002. Co-occurring Center for Excellence (COCE): Overview Papers: 1. Definitions and Terms relating to Co-occurring disorders. 2. Screening, Assessment, and Treatment Planning. 3. Overarching Principles to Address Co-occurring Disorders. 4. Addressing Co-occurring Disorders in Non-Traditional Settings. 5. Understanding Evidence Based Practice for Co-occurring Disorders. SAMHSA, Rockville, MD. 2006-2007. www.coce.org. Daley Dennis, Moss Howard, Dual Disorders: Counseling Clients with Chemical Dependency and Mental Illness, 3rd ed. Center City, MN. Hazelden. 2002. Daley Dennis, Coping with Dual Disorders: Addiction and Psychiatric Illness, Center City, MN. Daley DC & Spears J. A family guide to coping with dual disorders. Center City, MN: Hazelden. 2003 Delos Reyes CM & Ronis RJ. Statewide Implementation of Integrated Dual Disorder Treatment. The psychiatrist’s role. J. Dual Dx. (2006) 3:129-34l Double Trouble in Recovery. www.doubletroubleinrecovery.org . Drake RE. Management of substance use disorder in schizophrenia patients: current guidelines. CNS Drake, RE, Bartels, SJ, et. al. Treatment of substance abuse in severely mentally ill patients. J. Nervous Mental Disease (1993) 181:606-11. Drake RE, Burnette, Mary, eds. Integrated Dual Disorders Treatment (IDDT) Toolkit. SAMSHA. Drake, RE, Essock, SM, et. al. Implementing Dual Diagnosis services for clients with severe mental illness. Psych Services (2001) 52(4):469-476. Drake, RE, Mercer-McFAdden, C, et. al. (eds.) Readings in Dual Diagnosis. International Association of Psychosocial Rehabilitation Services. Columbia, MD. 1998. Drake RE, Mueser KT, & Brunette MF. Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psych 2007;6:131-6. Dual Diagnosis World Services. Dual Diagnosis Anonymous for Teens. (2002). Dual Diagnosis World Services, San Bernardino, CA. www.ddaworldwide.org Dual Recovery Anonymous. www.draonline.org Ekleberry, SC. Co-occurring Disorders: Personality Disorders and Addiction. In Press (2008). Also: [email protected]. Materials available on Dual Diagnosis Website: www.toad.net/~arcturus/dd/ddhome.htm. El-Guebaly N, et al. Smoking cessation approaches for persons with mental illness or addictive disorders. Psych Services (2002) 53:1166-70. Elliott DE, et al. Trauma-informed or trauma-denied: principles and implementation of trauma informed services for women (with co-occurring disorders). J. Comm Psychol. (2005) 3:461-77. Essock SM, Mueser KT, et al. Comparison of ACT and standard case management for delivering integrated treatment. Psych Services (2006) 57:185-95. Evans K & Sullivan JM. Treating Addicted Survivors of Trauma. Guilford, New York. 1995. Evans K & Sullivan JM. Dual diagnosis: Counseling the Mentally Ill Substance Abuser. 2nd Edition. Federation of Families for Children’s Mental Health. Blamed and ashamed: the treatment experiences of youth with co-occurring disorders and their families. October, 2000. Finkelstein N & Markoff LS. The Women Embracing Life and Living (WELL) Project. Using the relational model to develop integrated systems of care for women with alcohol/drug use and mental health disorders with histories of violence. Alcoholism Treatment Quarterly (2004). 22: 63-80. Fornili K & Haack MR. Promoting early intervention for substance use disorders through interdisciplinary education for health professionals. J. Add. Nurs. (2005) 16:153-60. Foundation Associates, Making Medication Part of Your Life (one of a series of pamphlets and workbooks). Nashville, TN. Foundation Associates. 2003. www.dualdiagnosis.org Frisman LK, et al. Outcomes of court based jail based diversion programs for people with co-occurring disorders. J. Dual Dx (2006): 2(2):5-24. Gagne C, White W, & Anthony W. Recovery: A common vision for the fields of mental health and addictions. Psych Rehab J (2007) 31:32-37. Geppert C, Minkoff K, Psychiatric Disorders and Medications, Center City, MN. Hazelden. 2003. Geppert C, Minkoff K, Psychiatric Medications and Recovery from Co-Occurring Disorders, Center Godley SH, Finch M, et. al. Case management for dually diagnosed individuals involved in the criminal justice system. J. Sub Ab. Treatment.(2000) 18:137-48. Grant BF et al. Co-occurrence of 12 month alcohol and drug use and personality disorders in the US. Goldfinger, SM, Shute, RK, et. al. Housing placement and subsequent days homeless among formerly homeless adults with mental illness. Psych Services (1999) 50:674-9. Hamilton, T. & Samples, P. The 12 Steps and Dual Disorders. Hazelden, Center City, MN. 1995. Harris M. Trauma Recovery and Empowerment Manual. Free Press. New York. 1998. Health Management Associates. Integrating publicly funded physical and behavioral health services. Hendrickson, EL, Schmal MS, & Ekleberry SC. Treating Co-Occurring Disorders: A Handbook for Mental Health and Substance Abuse Professionals 2005. Hendrickson EL. Designing, implementing, and managing treatment services for individuals with co-occurring disorders. Binghamton; Haworth Press. 2006. Henwood B & Padgett DK Re-evaluating the self-medication hypothesis among the dually diagnosed. Am. J. Hoffman NG, Mee-Lee D, & Schulman G. DAPPER- Dimensional assessment for patient engagement and recovery. Evince Clinical Assessments: Smithfield RI (2004) Illinois Alcohol and Other Drug Abuse Professional Certification Association. The Illinois standard for board registered MI/SA I/II. IAODAPCA, Springfield, IL. 1998. Institute of Medicine Committee on Crossing the Quality Chasm: adaptation top mental health and addictive disorders. Improving the quality of health care for mental and substance use conditions: quality chasm series. National Academy of Sciences 2006. www.nap.edu. Kalivas, P & Volkow, N. Addiction: a brain disorder of motivation and control. Am. J. Psych, 2005 Kerwin,M, WalkerSmith K, & Kirby K. Comparative analysis of state requirements for the training of substance abuse and mental health counselors. J Sub Ab Tr. (2006) 30:173-181. Kessler RC, Nelson CB et. al. The epidemiology of co-occurring addictive and mental disorders. Am. Kleinpeter C, et al. Providing recovery services for offenders with co-occurring disorders. J. Dual Dx. Knoll J. A tale of two crises: mental health treatment in corrections. J Dual Dx (2006) 3:7-22. Leshner AI. Addiction is a brain disease, and it matters. Science (1997) 278:45-7 Lucksted, A, Dixon, L, & Sembly, JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation patients. Psych Services (2000). 51:1544-8. Martino S, Carroll K et al: Dual diagnosis motivational interviewing: a modification for substance abusing patients with psychotic disorders. J. Sub Ab Tx (2002) 23:297-308. McGovern M, et al. Assessing the dual diagnosis capability of addiction treatment programs: the McLellan AT et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 284:1689-95 McLellan AT et al. Improving continuity of care in a public addiction system with clinical case management. Am J Addictions (2005) 14:426-40. McKillip, R. The Basics: a curriculum for co-occurring mental health and substance use disorders. 2004. Available from author: www.mckillipbasics.com Mee-Lee, D. Tips and Topics: a series on co-occurring disorders. www.dmlmd.com Mercer-McFadden C, Drake RE, et. al. Substance Abuse Treatment for People with Severe Mental Disorders: a program manager’s guide. NH-Dartmouth Psychiatric Research Center, Concord, NH. 1998. Mid-America Addiction Technology Transfer Center. A Collaborative Response: Addressing the needs of consumers with co-occurring substance use and mental health disorders. (including: Psychotherapeutic Medications 2006: what every counselor should know). Kansas City, Missouri, 2006. Web site: www.mattc.org., e-mail: [email protected], phone: 816-482-1100. Miller, WR & Rollnick S. Motivational Interviewing, 2nd Edition. Guilford Press, New York. 2002. Min SY, et al. Peer support for persons with co-occurring disorders and community tenure. Psych Minkoff, K. MIDAS: Mental illness drug and alcohol screening tool. 2001. Unpublished. Minkoff, K. Chair. CMHS Managed Care Initiative Panel on Co-occurring Disorders Co-occurring psychiatric and substance disorders in managed care systems: standards of care, practice guidelines, workforce competencies, and training curricula. Center for Mental Health Policy and Services Research. Philadelphia, 1998. Web site: www.med.upenn.edu/cmhpsr Minkoff, K. Developing standards of care for individuals with co-occurring psychiatric and substance disorders. Psych Services. 2001; 52:597-99. Minkoff, K. An integrated model for the management of co-occurring psychiatric and substance disorders in managed care systems. Dis. Mgt & Health Outcomes (2000).8(5):251-7. Minkoff K. Behavioral Health Recovery Management Service Planning Guidelines and CCISC Psychopharmacology Practice Guidelines for co-occurring psychiatric and substance disorders. www.bhrm.org, 2005. Minkoff, K. Program components of a comprehensive integrated care system for serious mentally ill patients with substance disorders. In: Minkoff K, Drake RE, eds. Dual Diagnosis of Major Mental Illness and Substance Disorder. New Directions for Mental Health Services, No 50. San Francisco, CA. Jossey-Bass, 1991, pp 13-27. Minkoff, K. What is Integration, Part I: (System and Services) Journal of Dual Diagnosis (2006) 2 (4): 133-144; What is Integration, Part II: (Programs and Practices). J. Dual Dx. (2007) 3 (1):149-158. What is Integration, Part III. (Clinicians and Competencies) J Dual Dx (2007) 3 (3/4):187-97. Minkoff K. Dual Diagnosis Enhanced Programs: Journal of Dual Diagnosis (2008), in press. Minkoff, K & Cline, C. CODECAT™ (Version 1): Co-occurring Disorders Educational Competency Assessment Tool/Clinician Core Competencies for Co-occurring Psychiatric and Substance Abuse Disorders, Zialogic 2001; COMPASS™ (Version 1): Co-morbidity Program Audit and Self-Survey for Behavioral Health Services/Adult and Adolescent Program Audit Tool for Dual Diagnosis Capability, Zialogic 2001; CO-FIT100™ 100 (Version 1): CCISC Outcome Fidelity and Implementation Tool, Zialogic 2002. Minkoff K & Cline C, Scope of Practice Guidelines for Addiction Counselors Treating the Dually Minkoff K & Cline C, Changing the World: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders. Psychiat Clin N Am 2004, 27: 727-743. Minkoff K & Cline C, Developing welcoming systems for individuals with co-occurring disorders: the role of the Comprehensive Continuous Integrated System of Care model. J Dual Diagnosis 2005, 1:63-89 Minkoff K &. Cline C, Dual diagnosis capability: moving from concept to implementation. Journal of Minkoff K & Cline C. Scope of practice guidelines for rehabilitation professionals working with individuals with co-occurring mental health and substance disorders. Rehab Review. Summer, 2006: 22-25. Minkoff, K & Drake, RE. Homelessness and dual diagnosis. In Lamb, HR (ed). Treating the Homeless Mentally Ill. Washington, DC, APPI. 1994. 221-35. Minkoff, K & Regner, J. Innovations in integrated dual diagnosis treatment in public managed care: the Choate dual diagnosis case rate program. J.Psychoactive Drugs. (1999). 31(1): 3-11. Minkoff K, Zweben J, Rosenthal R, & Ries R. Development of service intensity criteria and program categories for individuals with co-occurring disorders. J. Add. Dis (2003) 22 (supp 1):113-29. Montoya ID & Vocci F. Medications development for the treatment of nicotine dependence in individuals with schizophrenia. J. Dual Dx (2007) 3 (3/4) 113-50. Morrissey JP et al. Twelve month outcomes of trauma-informed interventions for women with co- occurring disorders. Psych Services (2005). 36:1213-1222. Morrissey JP et al. Extending assertive community treatment to criminal justice settings. CMHJ (2007) Mueser, KT, Bennett, M, & Kushner, MG. Epidemiology of substance use disorders among persons with chronic mental illnesses. In. Lehman, A & Dixon, LJ. Double Jeopardy. Chronic Mental Illness and Substance Use Disorders. Harwood Academic Publishers, Chur, Switzerland. 1995. Mueser, KT, Drake, RE, & Wallach, MA. Dual diagnosis: a review of etiological theories. Addictive Mueser KT, Drake RE, et al. Psychosocial interventions for adults with severe mental illnesses and co- occurring SUD: a review. J. Dual Dx. (2005) 1(2);57-82. Mueser KT & Fox L. A family intervention program for dual disorders (FIDD). Community MHJ. Mueser, KT & Noordsy, DL. Group treatment for dually diagnosed clients. In Drake, RE & Mueser, KT. Dual diagnosis of major mental illness and substance disorder. Part 2. Jossey-Bass, San Francisco. 1996. Mueser, KT, Noordsy, DL, Drake, RE, Fox, L. Integrated Treatment for Dual Disorders: A Guide to Effective Practice. New York, NY: Guilford Press, 2003. Najavits L, Seeking Safety, A Treatment Manual for PTSD and Substance Abuse. New York, NY: NASMHPD/NASADAD. The new conceptual framework for co-occurring mental health and substance use disorders. Washington, DC. NASMHPD 1998. NASMHPD/NASADAD. Financing and marketing the new conceptual framework. Washington, NASMHPD State Medical Directors Council. Integrating behavioral health and primary care services: opportunities and challenges for state mental health authorities. 2004. www.nasmhpd.org National Center for Trauma-Informed Care. http://mentalhealth.samhsa.gov/ncitc/ . National Council for Community Behavioral Healthcare. Behavioral health/primary care integration: draft background paper. 2002. www.nccbh.org National GAINS Center. The Courage to Change: Communities to create integrated services for people with co-occurring disorders in the justice system. GAINS Center, Delmar, NY. 1999. National Institute of Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide. NIAAA. 2005. www.niaaa.nih.gov/guide. National Institute of Drug Abuse, The science of addiction, drugs, brains, behavior. www.drugabuse.gov. Rockville, MD, NIH Publication 07-5605 (2007)B New Jersey Self-Help Clearinghouse. The self-help support group directory, 21st Edition. 800-367- New York City Department of Health and Mental Hygiene. Quality Impact (Basic CQI course, addressing co-occurring disorders). www.nyc.gov/html/doh/html/qi/qi.shtml (2006) Noether CD, Finkelstein N, et al. Design strengths and issues of SAMHSA’s women, co-occurring disorders and violence study. Psych Services (2005) 56:1233-36. Northeast Addiction Technology Transfer Center, Co-occurring Disorders in Adolescents: integrated assessment and treatment of the individual young person. www.neattc.org Erie, PA, NEATTC (2006) Northeast Addiction Technology Transfer Center, Co-occurring Disorders in Adults. www.neattc.org O’Brien C. Research advances in the understanding and treatment of addiction. Am J. Addict (2003) O’Brien, C. Anti-craving agents: a new category of psychotropic medications. American Journal of Ohio SAMI Coordinating Center of Excellence. Implementing IDDT: a step by step guide to organizational change. 2006. www.ohiosamiccoe.case.edu Ohio SAMI Coordinating Center of Excellence. SAMI Matters. Fall 2007. Volume 5, No. 1. Transformation Continues. www.ohiosamiccoe.case.edu Oklahoma Department of Mental Health and Substance Abuse Services. Change Agent Model Site Co- occurring Core L:evel Training. www.odmhsas.org (2006) Padgett DK et al. Housing first services for people who are homeless with co-occurring serious mental illness and substance abuse. Res on SW Practice (2006). 15(1): 74-83. Pennsylvania Department of Public Welfare and Department of Health. (2005) Co-occurring Disorder Capability Bulletin. Contact Rob Primrose at [email protected] Penn PE, et al. ADMIRE Plus: a treatment program for persons with co-occurring disorders. La Peters RH & Bartoi, MG. Screening and Assessment of Co-occurring Disorders in the Justice System. National GAINS Center, Delmar, NY. 1997. Petry NM et al. Contingency management interventions: from research to practice. Am J. Psychiat. Peters RH & Hills HA. Intervention strategies for offenders with co-occurring disorders. What works?. National GAINS Center, Delmar, NY. 1997. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am. Psychol. (1992) 47:1102-14. Quinlivan R & McWhirter DP. Designing a comprehensive care program for high cost clients in a managed care environment. Psych Services (1996) 47:813-5. RachBeisel, J, Scott, J. & Dixon, L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psych Services (1999). 50:1427-34. Ray GT, et al. Relationship between use of psychiatric services and five year alcohol and drug treatment outcomes. Psych Services (2005) 56:164-71. Regier, DA, Farmer ME, et. al. Comorbidity of mental disorders with alcohol and other drug abuse. Renner JA. Training psychiatrists to treat dual diagnosis patients. J. Dual Dx. (2007) 3: 125-136. Ridgely, MS, Lambert, D, et. al. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder. Psych Services (1999) 49:236-8. Ries, RK & Comtois KA. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schiz. Bull. (1997a) 23:239-46. Ries, RK & Comtois KA. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid substance disorder. Am. J. Addictions (1997b) 6(4):330-8. Ries, RK, Russo, J, et. al. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psych Services. 2001. 52(2):210-4. Roberts LJ, Shaner A, & Eckman TA. Overcoming addictions: skills training for people with schizophrenia. W.W. Norton, New York. 1999. Ronis RJ. The Ohio SAMI Coordinating Center of Excellence. J. Dual Dx (2004) 1(1):107-14. Sacks, S. Co-occurring disorders: promising approaches and research issues. J. Substance Use & Sacks, S, Sacks, JY, & DeLeon G. Treatment for MICAs: design and implementation of the modified TC. J. Psychoactive Drugs. (1999) 31:19-30. Sacks, S, Sacks J, et al. Modified TC for MICA offenders: crime outcomes. Behav Sci & the Law SAMHSA. Position statement on use of block grant funds to treat people with co-occurring disorders. Sciacca, K. Dual Diagnosis website and articles. http://pobox.com/dualdiagnosis. Scott CL, Lewis CF, &McDermott BE. Dual diagnosis among incarcerated populations: exception or SMART Recovery. www.smartrecovery.org Sowers W, et al. Level of care decision making in behavioral health services: the LOCUS and CALOCUS. Psych Services (2003) 54:1461-3. Steadman H, et al. Validation of the brief jail mental health screen. Psych Services (2005): 56:816-22. Steadman H & Naples M. Assessing the effectiveness of jail diversion programs for persons with SMI and SUD. Behav Sci & the Law (2005) 23:163-70. Steinberg ML & Williams J. Psychosocial treatments for individuals with schizophrenia and tobacco dependence. J. Dual Dx. (2007) 3 (3/4:): 99-112. Stuyt E & Meeker JL. Benefits of auricular acupuncture in tobacco free inpatient dual diagnosis treatment. J. Dual Dx. (2006) 2 (4): 41-52. Substance Abuse and Mental Health Services Administration. Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. November, 2002. Substance Abuse and Mental Health Services Administration. Transforming MH Care in America. Sciacca, K. Sciacca Comprehensive Service Development and Curriculum for MIDAA. Materials available on dual diagnosis website: http://pobox.com/~dualdiagnosis. E-mail. [email protected]. Shaner A, Eckman T, et al. Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psych Services (2003) 54:1287-9. Shaner A, Roberts LJ, et. al. Monetary reinforcement of abstinence from cocaine among mentally ill persons with cocaine dependence. Psych Services (1997) 48:807-10. Smith, J. Co-Occurring Substance Abuse and Mental Disorders: A Practitioner’s Guide. Jason Suncoast Practice and Research Collaborative (SPARC). Co-occurring Disorders Treatment Manual. Tampa: University of South Florida, Florida MH Institute. (2002) www.fmhi.usf.edu/mhlp/sparc/documents/manuals.htm. Tracy EM & Biegel DE. Personal social networks and dual disorders: a literature review. J. Dual Dx. Tsemberis, S & Eisenberg, RF. Pathways to Housi-ng: Supported housing for street dwelling homeless individuals with psychiatric disabilities. Psych Services (2000). 51(4):487-95. Tsemberis S, et al. Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J. Pub Health. (2004). 94:651-56. University of South Florida, Florida Mental Health Institute. Co-occurring disorders: a training series for counselors (2003). http://cmhwbt.fmhi.usf.edu/home/program_info/cod_info.cfm. (Free on line curriculum) Virginia DMHMRSAS. Substance abuse toolbox for primary care providers. 2004. Contact Weiss R, et. al. Integrated dual recovery curriculum for bipolar disorder and addiction. McLean White WL, et al. It’s time to stop kicking people out of addiction treatment. Counselor (April, 2005) 1- Wieder BL et al. Adapting IDDT for inpatient settings. J. Dual Dx. (2005) 2(1):101-08. Williams JM, Ziedonis D, et al. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psych Services (2004) 55:1064-66. Women for Sobriety. www.womenforsobriety.org World Health Organization. ASSIST v.3.0 (Alcohol, Smoking, and Substance Involvement Screening Ziedonis D & Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schiz. Bull. (1997) 23:229-38. Ziedonis D. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrums (2004) 9:892-904. Ziedonis D, Parks J, et al. Program and system level interventions to address tobacco among persons with schizophrenia. J. Dual Dx (2007) 3(3/4): 151-76 CO-OCCURRING DISORDER PSYCHOPHARMACOLOGY BIBLIOGRAPHY (2007)
Adelman S, Fletcher K, & Bahnassi A. Pharmacotherapeutic management strategies for mentally ill substance abusers. J. Subst. Abuse. Treatment. (1993) 10: 353-8. Albanese M, Khantzian E, et. al. Decreased substance use in chronically psychotic patients treated with clozapine. Am. J. Psych. (1994) 151:780-1. American Psychiatric Association Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, 2nd Ed. Am. J. Psychiat. (2007) 164 (4) Supp. Anton RF, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. Batki SL et al. Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia spectrum disorders. Am. J Addictions (2007) 16:253-59. Biederman, J, Wilens, T, et. al. Pharmacotherapy of ADHD reduces risk for substance use disorder. Brady KT & Roberts J. The pharmacotherapy of dual diagnosis. Psych Annals (1995) 25:344-52. Brunette MB, Noordsy DL, et al. Pharmacologic treatments for co-occurring sud in schizophrenia. J. Center For Substance Abuse Treatment. Clinical Guidelines for the use of buprenorphine. Treatment Improvement Protocol #40. CSAT, Washington, 2005. www.ncadi.samhsa.gov. . Ciraulo, DA & Nace, EP. Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Am. J. Addictions (2000) 9:276-84. Cornelius JR, et al. Fluoxetine in adolescents with comorbid sud and major depression: a 5 year follow up study. J. Dual Dx. (2005) 2(1):11-26. Fishman, SM. Responsible opioid prescribing: a physician’s guide. Federation of State Medical Boards. Washington. Waterford Life Sciences. (2007). Garbutt JC, et al. Efficacy and tolerability of long acting injectable naltrexone for alcohol dependence. Green AI. Substance abuse and schizophrenia: pharmacologic approaches. J. Dual Dx. (2007) 3:63-72. Kalivas, P & Volkow, N. Addiction: a brain disorder of motivation and choice. Am. J. Psych, Aug. Kleber. H. Pharmacologic treatments for heroin and cocaine dependence. Am. J. Addict. (2003) Kosten, TR. Management of anxiety in substance abusers. American Academy of Addiction Psychiatry Newsletter. Spring, 2000. AAAP, Prairie Village, KS Minkoff K. CCISC Psychopharmacology Practice Guidelines. www.bhrm.org, 2005. Montoya ID & Vocci F. Medications development for the treatment of nicotine dependence in individuals with schizophrenia. J. Dual Dx (2007) 3 (3/4) 113-50. Mueser KT, Noordsy DL, & Essock S. Use of disulfiram in the treatment of patients with dual Myrick H & Wright T. Comorbid ansiety and substance use disorders: diagnostic and treatment considerations. J. Dual Dx. (2005) 1(4):9-23 Pettinati HM, et al. Gender differences in response to sertraline in Type A alcohol dependence. Am J. Posternak MA & Mueller TI. Assessing the risks and benefits of benxos for anxiety disorders in patients with a history of SUD. Am. J. Addict. (2001) 10:48-68. Riggs PD & Davies RD. A clinical approach to integrating treatment for adolescent depression and substance abuse. J. Am Acad Child Adol Psychiat. (2002) 41(10)1-3. Sowers, W & Golden, S. Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. J. Psychoactive Drugs. (1999) 31:59-67 Stein MD, et al. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users. Am. J. Addict. (2005) 14:346-57 O’Brien, C. Anti-craving agents: a new category of psychotropic medications. American Journal of Tollefson GD, Montague-Clouse J, & Tollefson SL. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J. Clin. Psychopharm. (1992) 12:19-26. Wilens, TE, Spencer, TJ, et. al. A controlled clinical trial of bupropion for adult ADHD. Am J. Psych Zimmet SV, Strous RD, et. al. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorders. J. Clin. Psychopharm (2000) 20:94-8. DUAL DIAGNOSIS VIDEO MATERIALS
Promise of Recovery. Gerald T. Rogers Productions. 800-227-9100. Double Trouble. Gerald T. Rogers Productions. Out of the Tunnel; Into the Light. Hazelden. www.hazelden.org 800-328-9000. 12 Steps & Dual Disorders. Hazelden. Dual Diagnosis.(1994) NIDA, Rockville, MD. www.drugabuse.gov. Understanding Bipolar Disorder and Addiction (Dual Diagnosis Series), Hazelden www.hazelden.org Understanding Major Anxiety Disorders and Addiction Understanding Personality Problems and Addiction Understanding Posttraumatic Stress Disorder and Addiction. Dual Diagnosis: An Integrated Model for Treatment. Kenneth Minkoff, MD. Mental Illness Education Project. 800-343-5540. www.miepvideos.org Recovery Stories, DVD or VHS, (Co-Occurring Consumer Stories) CCSME/NAMI Maine, 207-878-6170, www.ccsme.org

Source: http://conferences.jbs.biz/treatment_homeless_08/PostWebSitePosting/2%20Tuesday,%20June%2017/2%20Minkoff%20plen/Hnd%20Co-Occurring%20Disorder%20Resource%20Bibliography.pdf